Mortality, Health Care Burden, and Treatment of CKD: A Multinational, Observational Study (OPTIMISE-CKD)

医学 肾脏疾病 危险系数 内科学 中止 糖尿病 心力衰竭 达帕格列嗪 2型糖尿病 队列研究 观察研究 重症监护医学 内分泌学 置信区间
作者
Navdeep Tangri,Maria Svensson,Johan Bodegård,Samuel Adamsson Eryd,Marcus Thuresson,Stefan Gustafsson,Tadashi Sofue
出处
期刊:Kidney360 [Lippincott Williams & Wilkins]
卷期号:5 (3): 352-362 被引量:34
标识
DOI:10.34067/kid.0000000000000374
摘要

Key Points Newly detected, moderately progressed CKD is associated with high clinical risks and health care costs. Most patients with moderately progressed CKD do not have diabetes and are at the same clinical risk as those with diabetes. Substantial inertia with kidney-protective treatment is observed when moderately progressed CKD is detected. Background Kidney-protective treatments (renin–angiotensin system inhibitors and sodium–glucose cotransporter-2 inhibitors [SGLT-2is]) can delay CKD progression, cardiovascular events, and death. Methods This observational cohort study used electronic health records and claims data from Japan, Sweden, and the United States to assess 1-year mortality/hospitalization event rates per 100 patient-years (PYs), cumulative hospital health care costs per patient, and kidney-protective treatment use before/after SGLT-2i (dapagliflozin) approval for CKD (2021) for patients with CKD stage 3–4 with/without type 2 diabetes (T2D). Results Among 449,232 patients (across-country median age range 74–81 years), 79% did not have T2D. Prevalence ranges for atherosclerotic cardiovascular disease and heart failure were 20%–36% and 17%–31%, respectively. Baseline kidney-protective treatment (renin–angiotensin system inhibitor and/or SGLT-2i) use was limited, especially among patients without T2D. Event rates were high for CKD (11.4–44.4/100 PYs) and heart failure (7.4–22.3/100 PYs). Up to 14.6% of patients had died within 1 year. Hospital costs were higher for CKD and heart failure than for atherosclerotic cardiovascular disease. After incident CKD, kidney-protective treatment initiation was low (8%–20%) and discontinuation was high (16%–27%), especially among patients without T2D. Conclusions Incident CKD was associated with substantial morbidity, mortality, costs, and undertreatment, especially in patients without T2D, who represented the majority of patients. This highlights an urgent need for early CKD detection and better kidney-protective treatment use in moderate CKD.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
甘蔗大王完成签到 ,获得积分10
1秒前
花花哈完成签到,获得积分10
2秒前
IY发布了新的文献求助30
2秒前
隐形松发布了新的文献求助10
3秒前
5秒前
思源的应助被amiee采纳,获得10
6秒前
6秒前
宠溺Ovo完成签到,获得积分10
6秒前
6秒前
6秒前
脑洞疼的应助被Z_ttkokil采纳,获得10
6秒前
7秒前
liumou发布了新的文献求助10
7秒前
ssswww完成签到,获得积分10
9秒前
竹竹完成签到,获得积分20
9秒前
秋月完成签到,获得积分10
9秒前
wwwwyg发布了新的文献求助10
9秒前
善始善终完成签到,获得积分0
10秒前
asdfzxcv的应助被宠溺Ovo采纳,获得30
11秒前
星辰大海的应助被zhuquanhao采纳,获得10
11秒前
12秒前
随霖完成签到 ,获得积分10
12秒前
Menand发布了新的文献求助10
12秒前
吴帆发布了新的文献求助10
12秒前
qq完成签到,获得积分20
13秒前
A_媛完成签到,获得积分10
13秒前
科研通AI2S的应助被隐形松采纳,获得10
14秒前
lotso的应助被开心德地采纳,获得10
15秒前
15秒前
17秒前
陈亚茹完成签到,获得积分10
18秒前
三国时代发布了新的文献求助30
18秒前
萝卜完成签到,获得积分10
18秒前
潘pan完成签到,获得积分10
19秒前
19秒前
White发布了新的文献求助10
19秒前
20秒前
科研通AI6.3的应助被likang采纳,获得10
20秒前
英姑的应助被格局采纳,获得10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189076
求助须知:如何正确求助?哪些是违规求助? 9576547
关于积分的说明 21848548
捐赠科研通 7787113
什么是DOI,文献DOI怎么找? 3435476
关于科研通互助平台的介绍 2559732
邀请新用户注册赠送积分活动 2482428